Association of visceral adiposity index (VAI) with prognosis in patients with metabolic syndrome and heart failure with reduced ejection fraction

Table 3 Relationship between different clinical indicators and adverse endpoint events

	Crude model		Model1		Model2		Model3
	HR (95%CI)	P	HR (95%CI)	P	HR (95%CI)	P	HR (95%CI)	P
Cardiac death
VAI	1.092 (1.056–1.130)	< 0.001	1.115 (1.076–1.155)	< 0.001	1.115 (1.076–1.155)	< 0.001	1.115 (1.076–1.156)	< 0.001
BMI	1.044 (1.003–1.087)	0.034	1.047 (1.003–1.092)	0.035	1.047 (1.003–1.092)	0.037	1.052 (1.005–1.102)	0.03
WC	1.011 (0.997–1.025)	0.139	1.008 (0.992–1.023)	0.333	1.007 (0.991–1.022)	0.399	1.007 (0.991–1.024)	0.404
TG	1.003 (1.002–1.004)	< 0.001	1.003 (1.002–1.004)	< 0.001	1.003 (1.002–1.004)	< 0.001	1.003 (1.002–1.004)	< 0.001
HDL-C	0.961 (0.943–0.979)	< 0.001	0.962 (0.944–0.981)	< 0.001	0.962 (0.944–0.980)	< 0.001	0.960 (0.942–0.978)	< 0.001
Readmission for heart failure
VAI	1.130 (1.102–1.158)	< 0.001	1.139 (1.110–1.168)	< 0.001	1.139 (1.110–1.169)	< 0.001	1.140 (1.111–1.170)	< 0.001
BMI	1.080 (1.053–1.109)	< 0.001	1.080 (1.051–1.109)	< 0.001	1.082 (1.053–1.111)	< 0.001	1.093 (1.061–1.126)	< 0.001
WC	1.025 (1.015–1.034)	< 0.001	1.026 (1.016–1.036)	< 0.001	1.027 (1.017–1.037)	< 0.001	1.029 (1.018–1.041)	< 0.001
TG	1.003 (1.002–1.004)	< 0.001	1.003 (1.002–1.004)	< 0.001	1.003 (1.002–1.004)	< 0.001	1.003 (1.002–1.004)	< 0.001
HDL-C	0.953 (0.942–0.965)	< 0.001	0.952 (0.941–0.964)	< 0.001	0.953 (0.941–0.964)	< 0.001	0.953 (0.941–0.965)	< 0.001

VAI: visceral adiposity index, BMI: body mass index, WC: waist circumference, TG: triglyceride, HDL-C: high-density lipoprotein cholesterol. Model1: sex, age. Model2: sex, age, smoking, drinking, MI. Model3: sex, age, smoking, drinking, MI, BNP, eGFR, LVEF

ISSN: 1471-2261